Literature DB >> 8163273

Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients.

K Parto1, M Kallajoki, H Aho, O Simell.   

Abstract

Lysinuric protein intolerance is an autosomal recessive disease caused by defective transport of cationic amino acids. Of the 38 lysinuric protein intolerance patients diagnosed in Finland since 1965, four pediatric patients have died. We describe the clinical courses and autopsy findings for these patients. All patients developed acute respiratory insufficiency. In addition to pulmonary hemorrhages, three of the patients had pulmonary alveolar proteinosis and one had cholesterol granulomas. Three patients had a clinically obvious renal insufficiency, but all four showed histologic signs of immune complex-mediated glomerulonephritis. The patients also developed hepatic insufficiency with fatty degeneration or cirrhosis. All patients showed anemia, thrombocytopenia, and a severe bleeding tendency. The bone marrow of three patients was hypercellular, but the amount of megakaryocytes was decreased in two cases. Amyloid was present in the lymph nodes and the spleen. Bone specimens showed osteoporosis. We conclude that pediatric patients with lysinuric protein intolerance are predisposed to develop pulmonary alveolar proteinosis and glomerulonephritis. They are also at risk of protein malnutrition in the active growth phase, probably due to higher requirements for total nitrogen and amino acids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163273     DOI: 10.1016/0046-8177(94)90150-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

1.  B and T cell immunity in patients with lysinuric protein intolerance.

Authors:  M Lukkarinen; K Parto; O Ruuskanen; O Vainio; H Käyhty; R M Olander; O Simell
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Lysine triggers apoptosis through a NADPH oxidase-dependent mechanism in human renal tubular cells.

Authors:  Daniela Verzola; Annamaria Famà; Barbara Villaggio; Maia Di Rocco; Alchiede Simonato; Elena D'Amato; Fabio Gianiorio; Giacomo Garibotto
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

3.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

4.  Necropsy findings in lysinuric protein intolerance.

Authors:  D T McManus; R Moore; C M Hill; C Rodgers; D J Carson; A H Love
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

5.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.

Authors:  T Lauteala; P Sistonen; M L Savontaus; J Mykkänen; J Simell; M Lukkarinen; O Simell; P Aula
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

8.  Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

Authors:  Mari Kärki; Kirsti Näntö-Salonen; Harri Niinikoski; Laura M Tanner
Journal:  JIMD Rep       Date:  2015-06-30

Review 9.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

10.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.